Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

Lungpacer Medical USA, Inc.

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

Lungpacer Medical USA, Inc.

Regulatory records
8
Linked recall entries
0
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 8 FDA records to the applicant name Lungpacer Medical USA, Inc.. It includes 1 original PMA approval. 6 entries are PMA supplements. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Dec 4, 2024 to Sep 25, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code SDL appears in 8 of the 8 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P240012, with 8 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes. 1 linked filing has a current plain-language explanation checked against the recorded FDA decision.

Applicant mailing address recorded by FDA: 260 Sierra Dr., Suite 116, Exton, PA, 19341. Recorded on P240012/S008, decision dated Sep 25, 2026.

Changes described in PMA records

P240012/S008: AeroPace System

The FDA database lists decision APPR for supplement P240012/S008 to AeroPace® System, submitted by Lungpacer Medical USA, Inc., dated 2026-09-25. The supplement type is Real-Time Process with reason Process Change - Manufacturer/Sterilizer/Packager/Supplier. The source statement describes approval for changes to the temperature control components in the Neurostimulation Console and packaging changes for the Console. The product code is SDL, categorized as a transvenous temporary phrenic nerve stimulator under Anesthesiology.

The P240012 prefix links this supplement to the original PMA of that number, but a supplement is not a new approval of the whole system. The statement reports a regulatory decision on specified component and packaging changes; it does not establish safety or clinical effectiveness. Specifics absent from the record include which temperature control components changed, the nature of the packaging changes, and any supporting data.

FDA approval-order wording

Approval for changes to the temperature control components in the Neurostimulation Console and packaging changes for the Console.

Sep 25, 2026 · Real-Time Process

P240012/S007: AeroPace System

FDA’s recorded scope: Approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240012

Jun 22, 2026 · Normal 180 Day Track No User Fee

P240012/S006: AeroPace System

FDA’s recorded scope: Approval for dimensional changes to the luer connectors of the Neurostimulation Catheter.

Jun 22, 2026 · Real-Time Process

P240012/S005: AeroPace System

FDA’s recorded scope: Approval of the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240012.

Feb 20, 2026 · Normal 180 Day Track No User Fee

P240012/S004: AeroPace System

FDA’s recorded scope: Addition of two suppliers of PCBAs included in the assembly of the Neurostimulation Console and Handheld Controller.

Jan 14, 2026 · 30-Day Notice

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

Regulatory record history

  1. AeroPace System

    P240012/S008 · PMA supplement
  2. AeroPace System

    P240012/S007 · PMA supplement
  3. AeroPace System

    P240012/S006 · PMA supplement
  4. AeroPace System

    P240012/S005 · PMA supplement
  5. AeroPace System

    P240012/S004 · PMA supplement
  6. AeroPace System

    P240012/S003 · PMA supplement
  7. AeroPace System

    P240012/S002 · PMA supplement
  8. AeroPace System

    P240012 · PMA decision
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.